Related Experiment Video
Updated: Mar 16, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Does Reducing Basal Insulin During Ramadan Fasting by Children and Adolescents with Type 1 Diabetes Decrease the Risk
Asma Deeb1, Nabras Al Qahtani1, Salima Attia1
11 Paediatric Endocrinology Department, Mafraq Hospital , Abu Dhabi, United Arab Emirates .
Reducing basal insulin during Ramadan fasting did not lower hypoglycemia risk in adolescents with type 1 diabetes. Insulin pump use showed no difference from multiple daily injections regarding hypoglycemia frequency.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Diabetes Management
Background:
- Ramadan fasting poses a risk of hypoglycemia for type 1 diabetes patients.
- Optimal basal insulin adjustment strategies during Ramadan are not well-established.
- This study addresses the lack of data on insulin adjustment during fasting periods.
Purpose of the Study:
- To investigate if reducing basal insulin during Ramadan fasting decreases symptomatic hypoglycemia in children and adolescents with type 1 diabetes.
- To evaluate the impact of basal insulin reduction on hypoglycemia frequency during Ramadan.
- To compare hypoglycemia occurrence between insulin pump users and multiple daily injection (MDI) users.
Main Methods:
- Enrolled children and adolescents with type 1 diabetes intending to fast during Ramadan.
- Collected data on fasting days, symptomatic hypoglycemia, and basal insulin doses via logbooks.
- Analyzed data from logbooks, glucometers, and insulin pump downloads.
Main Results:
- Sixty-eight patients' data were analyzed; 39 experienced hypoglycemia requiring breaking fast.
- Reducing basal insulin did not significantly alter the frequency of hypoglycemia.
- Hypoglycemia occurrence did not differ significantly between insulin pump users and MDI users.
Conclusions:
- This is the first study on basal insulin reduction impact on adolescent hypoglycemia during Ramadan.
- Reducing basal insulin during Ramadan fasting is not effective in decreasing symptomatic hypoglycemia risk.
- Insulin pump therapy and MDI showed similar hypoglycemia frequencies in this fasting cohort.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
06:13Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hypoglycemia and Glucagon
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...